Detection of substandard fixed-dose combination tuberculosis drugs using thin-layer chromatography

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 11 SUPPL. 3, 1999, Pages

  Kenyon, T A ^a,b,e   Kenyon, A S ^c   Kgarebe, B V ^d   Mothibedi, D ^d   Binkin, N J ^a,b   Layloff, T P ^c  

^a BOTUSA Project   (Botswana)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF BOTSWANA   (Botswana)

^e American Embassy Gaborone   (United States)

Author keywords

Counterfeit; Drug quality; Drug resistant TB; Drugs; Fixed dose combinations; Pharmaceutical management; Thin layer chromatography; Treatment; Tuberculosis

Indexed keywords

PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

CONFERENCE PAPER; DRUG DETERMINATION; DRUG FORMULATION; DRUG QUALITY; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; STANDARD; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTITUBERCULAR AGENTS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, LIQUID; CHROMATOGRAPHY, THIN LAYER; DRUG COMBINATIONS; DRUG INDUSTRY; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0032711874     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. World Health Organisation. Treatment of tuberculosis. Guidelines for National Programmes. 2nd ed. WHO/TB/97.220. Geneva, Switzerland: WHO, 1997.
2. Toman K. Tuberculosis. Case finding and chemotherapy. Questions and answers. Geneva, Switzerland: WHO, 1979: 84-86.
3. Pablos-Mendez A, Raviglione M G, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med 1998; 338: 1641-1649.
4. Mahmoudi A, Iseman M D. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. JAMA 1993; 270: 65-68.
5. Acocella G. Human bioavailability studies. Bull Int Union Tuberc Lung Dis 1989; 64(1): 38-40.
6. Kenyon A S, Layloff T P. Rapid screening of pharmaceuticals by thin-layer chromatography. Pharm/95.290. Geneva, Switzerland: WHO, 1995.
7. Kenyon A S, Flinn P E, Layloff T P. Rapid screening of pharmaceuticals by thin-layer chromatography: analysis of essential drugs by visual methods. J AOAC Intl 1995; 78: 41-49.
8. US Pharmacopoeia, National Formulary. Rockville, Maryland: United States Pharmacopeial Convention [23] 1995: pp 846, 1381 and 2976.
9. Rom W N, Garay S. Tuberculosis. Boston: Little Brown & Co, 1996: pp 779, 799, and 800.
10. Long M W, Snider D E Jr, Farer L S. US Public Health Service Cooperative trial of three rifampicin-isoniazid regimens in treatment of pulmonary tuberculosis. Am Rev Respir Dis 1979; 119: 879-894.
11. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149: 1359-1374.
12. Pécoul B, Chirac P, Trouiller P, Pinel J. Access to essential drugs in poor countries. A lost battle? JAMA 1999; 281: 361-367.
13. O'Brien K L, Selanikio G D, Hecdivert C, et al. Epidemic of pediatric deaths from acute renal failure caused by dicthylene glycol poisoning. JAMA 1998; 279: 1175-1180.
14. Kenyon A S, Xiaoye Shi, Wang Y, Har N W, Prestridge R, Sharp K. Simple, at-site detection of diethylene glycol/ethylene glycol contamination of glycerin and glycerin-based raw materials by thin-layer chromatography. J AOAC Intl 1998; 81: 44-50.
15. Kenyon T A, Kenyon A S, Sibiya T. Drug quality screening in developing countries: establishment of an appropriate laboratory in Swaziland. Bull World Health Organ 1994; 72: 615-620.